BioMime Morph SES system demonstrates favorable clinical outcomes in very long coronary lesions (≤56mm) at six-month clinical follow-up in a real-world global registry.
Avoids overlapping and associated restenosis and revascularization
Tapers as per vessel anatomy
Reduces procedural time as single stent is deployed
Economical – one stent versus use of multiple overlapping stents